A similar situation holds true for chemicals that act through mechanisms of cardiovascular toxicity
, which were allocated to toxicity categories 2, 3, and 4 (33%, 19%, and 40%, respectively).
induced by cancer treatment is a common and pressing issue for cardiologists and oncologists.
"Our data suggest that short-term exposure of endothelial cells to flavoring compounds used in tobacco products have adverse effects on endothelial cell phenotype that may have relevance to cardiovascular toxicity
," the authors write.
SCBs are associated with cardiovascular toxicity
. The most common cardiovascular effect is sinus tachycardia, often in conjunction with hypertension, as seen in our patient.
of nicotine: Implications for nicotine replacement therapy.
Navarova, "Cardiovascular toxicity
of the first line cancer chemotherapeutic agents: doxorubicin, cyclophosphamide, streptozotocin and bevacizumab," Neuro endocrinology letters, vol.
of novel psychoactive drugs: lessons from the past.
The pathogenesis of cardiovascular toxicity
related to COC use has been reviewed recently [8-10].
With longer survival, cancer patients are now subject to the cardiovascular effects of aging as well as potential cardiovascular toxicity
from modern cancer agents.
As reported previously, the FDA now requires that all new drugs approved for diabetes rule out cardiovascular toxicity
rather than simply showing the agent lowers HbA1c levels.
Cardiac toxicity of local anesthetics: Cardiovascular toxicity
produces changes in cardiac conduction, impairment of contractility and myocardial metabolic changes.